- Home
- / Gland Pharma
Gland Pharma
Stock Price
₹1.6 K
2024-10-28
Market Capitalization
₹266.1 B
2024-10-28
Revenue
₹64.3 B
FY, 2026
Gland Pharma Summary
Company Summary
- Overview
- Gland Pharma is a company manufacturing generic injectables. It offers sterile injectables, oncology, and ophthalmic products. In addition, the company provides delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops.
- Type
- Public
- Status
- Active
- Founded
- 1978
- HQ
- Hyderabad, IN | view all locations
- Website
- https://glandpharma.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
KVGK Raju, Chief Technical Officer
Ravi Shekhar Mitra, Chief Financial Officer
Yiu Kwan Stanley Lau, Chairman and Independent Director
Operating MetricsView all
Production Lines
28
FY, 2023
Countries
60
FY, 2023
Stock Keeping Units
35
20.5%
FY, 2023
LocationsView all
9 locations detected
Hyderabad, TS HQ
India
Plot No. 11 & 84, TSIIC Phase: IV Pashamylaram (V), Patancheru (M), Sangareddy District
Trenton, NJ
United States
208 W State St
Hyderabad, TS
India
No. 143-148, 150 & 151 Near Gandimaisamma 'X' Roads D.P. Pally, Dundigal Gandimaisamma Mandal Medchal-Malkajgiri District
Hyderabad, TS
India
Plot No.9, Sy No.542(P), Genome Valley, Kolthur Village, Shamirpet Mandal, Medchal District
Hyderabad, TS
India
Unit-I and Unit-II, Plot No.54, 55 & 64 – 68, Phase – III, Industrial Park, Pashamylaram (V),Patancheru (M), Sangareddy District
Hyderabad, TS
India
Unit-II, Plot No.42-52, Phase – III Industrial Park, Pashamylaram (V) Patancheru
Gland Pharma Financials
Summary Financials
- Revenue (FY, 2026)
- ₹64.3B
- Gross profit (FY, 2026)
- ₹45.0B
- Net income (FY, 2026)
- ₹10.3B
- Cash (FY, 2026)
- ₹33.6B
- EBIT (FY, 2026)
- ₹15.0B
- Enterprise value
- $242.1B